about
Incorporated in 1978, Biocon is engaged in the manufacture of biotechnology products and research services. The company's business include Generics with diverse portfolio encompasses a wide range of complex molecules, including cardiovascular medicat...
Read More
394.65
4.20
(1.08%)
18.2M
NSE+BSE Volume
High volume today
NSE 16 Jul, 2025 3:31 PM (IST)
US FDA Approval
Biocon gets US FDA approval for Kirsty insulin drug with annual sales of $1.9 billion
See details